Skip to content

DexCom DXCM Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$930.4M+11.3%$836.3M+16.0%$720.7M+26.1%$571.5M+6.8%$535.2M-7.1%
$258.9M+2.8%$251.8M+3.0%$244.4M+3.5%$236.1M+4.8%$225.2M+3.4%
$168.7M+5.7%$159.6M-4.9%$167.9M+1.0%$166.2M+0.4%$165.6M-2.8%
$1.78B+23.7%$1.44B-0.5%$1.45B+46.6%$987.7M+2.4%$964.1M-2.6%
$353.1M-2.9%$363.5M-5.9%$386.2M-7.4%$416.9M+7.2%$388.9M+8.4%
-$182.1M+12.2%
-$1.72B-2.2%-$1.69B-917%-$165.8M+77.2%-$727.3M0.0%-$727M+1.1%
$1.43B+32.7%$1.08B+1.4%$1.06B+86.0%$570.8M-0.8%$575.2M-8.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does DexCom generate?
DexCom (DXCM) generated $1.8B in operating cash flow over the trailing twelve months.
What is DexCom's free cash flow?
After $353.1M of capital expenditures, DexCom's free cash flow was $1.4B over the trailing twelve months, up 148.5% year over year.
Where does DexCom's cash flow data come from?
Every line is extracted from DexCom's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.